You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic Neuroendocrine Neoplasm

Showing 1 - 25 of 6,048
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Genetic Predisposition Testing Program for Pancreatic

Not yet recruiting
  • Pancreatic Neuroendocrine Neoplasm
  • Hereditary Cancer Panel
  • Los Angeles, California
  • +2 more
Feb 17, 2023

Pancreatic Neuroendocrine Tumor Trial in Shanghai (Nimotuzumab)

Not yet recruiting
  • Pancreatic Neuroendocrine Neoplasm
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Apr 4, 2022

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

Recruiting
  • Neuroendocrine Tumor Grade 3
  • +2 more
  • Tianjin, Tianjin, China
    Rui Liu
Nov 17, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • +4 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jan 14, 2023

Neuroendocrine Carcinoma of Pancreas, Duodenum Carcinoma, Pancreas Tumor Trial in Amsterdam, Rotterdam (Stereotactic

Recruiting
  • Neuroendocrine Carcinoma of Pancreas
  • +6 more
  • Stereotactic radiotherapy
  • Amsterdam, North-Holland, Netherlands
  • +1 more
Nov 29, 2022

Pancreatic Cancer Dietary Assessment Study

Completed
  • Pancreatic Neoplasm
  • +3 more
  • Pancreo-KIT breath test
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 1, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Pancreas Tumor Trial in Roma, Rome (EUS guided radiofrequency ablation)

Recruiting
  • Neuroendocrine Tumors
  • +3 more
  • EUS guided radiofrequency ablation
  • Roma, RM, Italy
  • +1 more
Feb 10, 2022

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Models in Neuroendocrine Neoplasm

Recruiting
  • Neuroendocrine Neoplasm
  • Biopsy, open or laparoscopic surgery
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Sep 19, 2021

Metastatic Malignant Tumor in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +4 more
  • Ames, Iowa
  • +5 more
Dec 3, 2021

Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Young TIL
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Lymph Node Metastases by NF-PanNENs

Recruiting
  • Non Functioning Pancreatic Endocrine Tumor
    • Milan, Italy
      IRCCS San Raffaele Hospital
    Aug 23, 2022

    Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis

    Not yet recruiting
    • Neuroendocrine Neoplasm
    • Biopsy/surgical tissue and peripheral blood
    • Shanghai, Shanghai, China
      Department of Pancreatic Surgery, Fudan University Shanghai Canc
    Jun 12, 2021

    Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

    Recruiting
    • Metastatic Lung Small Cell Carcinoma
    • +16 more
    • Phoenix, Arizona
    • +10 more
    Mar 25, 2022

    Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

    Recruiting
    • Neuroendocrine Neoplasm
    • Biospecimen Collection
    • +4 more
    • Duarte, California
    • +3 more
    Jan 12, 2023

    Appendix Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Seattle (Acupuncture Therapy, Acupressure Therapy, Oral

    Recruiting
    • Appendix Carcinoma
    • +12 more
    • Acupuncture Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Apr 11, 2022

    Liver Metastases, Colorectal Cancer, Anal Canal Cancer Trial in São Paulo (SBRT)

    Recruiting
    • Liver Metastases
    • +3 more
    • SBRT
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de São Paulo
    Dec 15, 2021

    Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumor, Gastro-enteropancreatic Neuroendocrine Tumor Trial in Taiwan (CVM-1118)

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Kaohsiung, Taiwan
    • +6 more
    Aug 24, 2021

    Viewpoints on Social Representations and Rationale Concerning

    Terminated
    • Non-resectable Metastatic Cancer of the Lung
    • +7 more
    • Interviews
    • Questionnaires
    • Dijon, France
      Chu Dijon Bourogne
    Apr 14, 2022

    Through Detection of Elastase-1 Combined With Other Examinations

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +5 more
    • Pancreatic elastase-1 in blood serum
    • Jinan, Shandong, China
      Ning Zhong
    Sep 10, 2023

    Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • +6 more
    • (no location specified)
    Aug 4, 2023

    Multi-dimensional Fragmentomic Assay for Early Detection of

    Not yet recruiting
    • Pancreatic Neuroendocrine Tumor
    • Fragmentomic profiles of plasma cfDNA
    • (no location specified)
    Apr 27, 2023

    Development of New Personalised 3D Preclinical Models of

    Recruiting
    • Pancreatic Neuroendocrine Tumor
      • Milan, MI, Italy
        IRCCS San Raffele Institute
      Nov 2, 2023

      Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

      Completed
      • Pancreatic Neuroendocrine Tumor G2
      • Octreotide LAR
      • (no location specified)
      Oct 17, 2023